Y Takemura Selected Research

Y Takemura Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 04/2004 - 01/2000
6	Neoplasms (Cancer) 02/2008 - 06/2000
4	Leukemia 09/2001 - 02/2000
3	Infections 07/2005 - 09/2001
3	Carcinogenesis 11/2001 - 06/2000
2	Atherosclerosis 02/2008 - 01/2000
2	Insulin Resistance 03/2004 - 01/2001
1	Osteoarthritis 03/2016
1	Osteonecrosis (Kienbock's Disease) 03/2016
1	Endometriosis 12/2009
1	Emphysema 06/2008
1	Hypoadiponectinemia 06/2008
1	Cerebral Infarction 02/2008
1	Colorectal Neoplasms (Colorectal Cancer) 02/2008
1	Inflammation (Inflammations) 02/2008
1	Hyperthermia 01/2008
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2005
1	Weight Loss (Weight Reduction) 04/2004
1	Hypertension (High Blood Pressure) 03/2004
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2003
1	Shock 01/2003
1	Spontaneous Abortion (Miscarriage) 01/2003
1	Lymphoma (Lymphomas) 09/2001
1	Neoplasm Metastasis (Metastasis) 09/2001
1	Breast Neoplasms (Breast Cancer) 09/2001
1	Asthma (Bronchial Asthma) 07/2001
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2000
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2000
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2000
1	Hematologic Neoplasms (Hematological Malignancy) 02/2000
1	Hypercholesterolemia 01/2000
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2000

Drug/Important Bio-Agent (IBA)

3	ThrombomodulinIBA 05/2001 - 11/2000
2	C-Reactive ProteinIBA 07/2005 - 10/2001
2	Insulin (Novolin)FDA Link 04/2004 - 11/2003
2	Triglycerides (Triacylglycerol)IBA 03/2004 - 11/2000
2	fibrin fragment D (D-dimer)IBA 11/2003 - 11/2000
2	FlavonoidsIBA 11/2001 - 06/2000
1	Oral ContraceptivesIBA 12/2009
1	AdiponectinIBA 06/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2005
1	AntigensIBA 04/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2004
1	LipidsIBA 04/2004
1	Plasminogen Activator Inhibitor 1IBA 04/2004
1	Doxazosin (Cardura)FDA LinkGeneric 03/2004
1	Nonesterified Fatty Acids (NEFA)IBA 03/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2004
1	CoagulantsIBA 11/2003
1	Fibrinogen (Factor I)FDA Link 11/2003
1	Interleukin-6 (Interleukin 6)IBA 11/2003
1	GlucocorticoidsIBA 01/2003
1	Anticardiolipin AntibodiesIBA 01/2003
1	Ether (Diethyl Ether)IBA 11/2001
1	QuercetinIBA 11/2001
1	Catalytic RNA (Ribozymes)IBA 09/2001
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2001
1	Folic Acid AntagonistsIBA 09/2001
1	RNA Polymerase IIIIBA 09/2001
1	Etoposide (VP 16)FDA LinkGeneric 09/2001
1	Liposomes (Liposome)IBA 09/2001
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2001
1	beraprostIBA 05/2001
1	Nitric Oxide DonorsIBA 02/2001
1	methyl- 2- hydroxyimino- 5- nitro- 6- methoxy- 3- hexeneamideIBA 02/2001
1	nobiletinIBA 02/2001
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2001
1	3,3',4',5,6,7,8-heptamethoxyflavoneIBA 02/2001
1	von Willebrand FactorIBA 01/2001
1	AnticoagulantsIBA 11/2000
1	Protein CIBA 11/2000
1	Prothrombin (Factor II)IBA 11/2000
1	Thrombin FDA Link 11/2000
1	Fibrinolysin FDA Link 11/2000
1	Thymidylate SynthaseIBA 07/2000
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2000
1	raltitrexed (D 1694)IBA 07/2000
1	Pharmaceutical PreparationsIBA 07/2000
1	Collagen Type I (Type I Collagen)IBA 04/2000
1	Procollagen Type IIBA 04/2000
1	Indicators and Reagents (Reagents)IBA 04/2000
1	RNA (Ribonucleic Acid)IBA 02/2000
1	Advanced Glycation End ProductsIBA 01/2000
1	LDL Receptors (LDL Receptor)IBA 01/2000
1	Estrogens (Estrogen)FDA Link 01/2000

Therapy/Procedure

3	Therapeutics 01/2008 - 09/2001
1	Arthrodesis 03/2016
1	Glycemic Control 04/2004
1	PE regimen 09/2001
1	Nutritional Support (Artificial Feeding) 07/2001
1	Drug Therapy (Chemotherapy) 02/2000